Kelun-Biotech

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (Kelun Botai, HKEX: 6990), a Chengdu-based subsidiary of Sichuan Kelun Pharmaceutical (SZSE: 002422) established in 2016, is an innovative biopharmaceutical company focused on the research, development, manufacturing, and commercialization of novel drugs. It specializes in antibody-drug conjugates (ADCs) and other conjugated therapies across both large-molecule and small-molecule modalities, targeting oncology and autoimmune diseases. The company operates several core drug-discovery platforms and maintains a pipeline of 30+ candidates with multiple approved and clinical-stage programs. It was surfaced as a portfolio company of idg-capital and added to the API Evangelist network; as a pharmaceutical manufacturer it publishes no public developer or API surface.

Kelun-Biotech is profiled on the APIs.io network. Tagged areas include Company, Healthcare, Pharmaceuticals, Biotechnology, and Oncology.

🌐 Visit website 📡 Source on GitHub

5.7/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyHealthcarePharmaceuticalsBiotechnologyOncologyDrug DevelopmentAntibody-Drug ConjugateChina

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 5.7/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 0.0 / 20

Commercial Clarity 0.0 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/kelun-biotech: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Resources

Company 3

The organization behind the API

Website

Website

Careers

Careers

InvestorRelations

InvestorRelations

Source (apis.yml)

aid: kelun-biotech
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/kelun-biotech.png
name: Kelun-Biotech
description: 'Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (Kelun Botai, HKEX: 6990), a Chengdu-based subsidiary of Sichuan
  Kelun Pharmaceutical (SZSE: 002422) established in 2016, is an innovative biopharmaceutical company focused on the research,
  development, manufacturing, and commercialization of novel drugs. It specializes in antibody-drug conjugates (ADCs) and
  other conjugated therapies across both large-molecule and small-molecule modalities, targeting oncology and autoimmune diseases.
  The company operates several core drug-discovery platforms and maintains a pipeline of 30+ candidates with multiple approved
  and clinical-stage programs. It was surfaced as a portfolio company of idg-capital and added to the API Evangelist network;
  as a pharmaceutical manufacturer it publishes no public developer or API surface.'
url: https://raw.githubusercontent.com/api-evangelist/kelun-biotech/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- idg-capital
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-19'
tags:
- Company
- Healthcare
- Pharmaceuticals
- Biotechnology
- Oncology
- Drug Development
- Antibody-Drug Conjugate
- China
apis: []
common:
- type: Website
  url: https://www.kelun-biotech.com
- type: Careers
  url: http://kelunbotai.zhiye.com/
- type: InvestorRelations
  url: https://www.kelun-biotech.com/news.aspx?mid=157
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence